MEK抑制剂CI-1040（PD 184352）对正常和骨髓增生异常综合征骨髓祖细胞生长的影响。 - Suppr | 超能文献

Effects of the MEK inhibitor CI-1040 (PD 184352) on progenitor growth from normal and myelodysplastic marrow.

作者信息

Steensma David P, Mesa Ruben A, Reeder Terra L, Tefferi Ayalew, Kaufmann Scott H

出版信息

Haematologica. 2003 Sep;88(9):1072-4.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Effects of the MEK inhibitor CI-1040 (PD 184352) on progenitor growth from normal and myelodysplastic marrow.MEK抑制剂CI-1040（PD 184352）对正常和骨髓增生异常综合征骨髓祖细胞生长的影响。

Haematologica. 2003 Sep;88(9):1072-4.

2

[Effects on bone marrow during stimulation of hematopoietic stem cells with recombinant human interleukin-3].

Verh Dtsch Ges Pathol. 1990;74:111-5.

3

Modulation by retinoic acid of the growth of bone marrow cell progenitors from patients with myelodysplastic syndrome.

Haematologica. 1989 Jan-Feb;74(1):25-8.

4

Role of the p38 mitogen-activated protein kinase pathway in cytokine-mediated hematopoietic suppression in myelodysplastic syndromes.p38丝裂原活化蛋白激酶通路在骨髓增生异常综合征细胞因子介导的造血抑制中的作用

Cancer Res. 2005 Oct 1;65(19):9029-37. doi: 10.1158/0008-5472.CAN-04-4555.

5

Biologic and clinical implications of marrow culture studies in the myelodysplastic syndromes.

Semin Hematol. 1996 Apr;33(2):163-75.

6

[Myelodysplastic syndromes].[骨髓增生异常综合征]

Rev Invest Clin. 1997 May;49 Suppl 1:15-21.

7

[Myelodysplastic syndromes--diagnostic and therapeutic problems].

Przegl Lek. 1988;45(11):801-11.

8

[Primary myelodysplastic syndromes].[原发性骨髓增生异常综合征]

Rev Med Brux. 1988 Sep;9(6):327-33.

9

[Secondary dysmyelopoiesis in patients with myelodysplastic syndromes].[骨髓增生异常综合征患者的继发性骨髓生成异常]

Ter Arkh. 2014;86(7):97-103.

10

GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.GATA-1转录因子在骨髓增生异常综合征的骨髓造血祖细胞CD34(+)和红系细胞CD71(+)中上调。

Am J Hematol. 2007 Oct;82(10):887-92. doi: 10.1002/ajh.20993.

引用本文的文献

1

Thrombopoietin promotes NHEJ DNA repair in hematopoietic stem cells through specific activation of Erk and NF-κB pathways and their target, IEX-1.血小板生成素通过特异性激活 Erk 和 NF-κB 通路及其靶标 IEX-1 促进造血干细胞中的 NHEJ DNA 修复。

Blood. 2014 Jan 23;123(4):509-19. doi: 10.1182/blood-2013-07-515874. Epub 2013 Nov 1.

2

Overcoming resistance to molecularly targeted anticancer therapies: Rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignancies.克服对分子靶向抗癌疗法的耐药性：基于EGFR和MAPK抑制的实体瘤和血液系统恶性肿瘤的合理联合用药

Drug Resist Updat. 2007 Jun;10(3):81-100. doi: 10.1016/j.drup.2007.03.003. Epub 2007 May 7.